Bone marrow biopsy revealed proliferation of atypical lymphocytes, and immunostaining was positive for Cluster Designation (CD)79a, CD20, and bcl‐2, which led to a diagnosis of splenic marginal zone lymphoma (SMZL). This evidence concerns the gene BCL2 and splenic marginal zone lymphoma.